This New Bill Could Effectively End Compounded GLP-1 Access for Hundreds of Thousands Dave Knapp Dec 11, 20255 min read These Are The Top Threats to Compounded GLP-1's Dave Knapp Oct 27, 20251 min read The Weekly Dose 5/20/25 Dave Knapp Aug 28, 20252 min read OFA Provides EXCLUSIVE Statement to OTP on Tirzepatide Ruling + Viewers Provide More Proof of Continued Shortages Dave Knapp Aug 28, 20252 min read Compounded GLP-1 Under Fire Again: What Todays Study Didnt Tell Us Dave Knapp Apr 28, 20253 min read Lilly Sues Four More Over Compounded Tirzepatide and the Fallout Has Just Begun Dave Knapp Apr 23, 20253 min read Lilly Suing Strive and Empower Pharmacies over Compound Tirzepatide Dave Knapp Apr 1, 20252 min read Transcript: On The Pen Interview with OFA Chairman, Lee Rosebush Dave Knapp Mar 27, 202523 min read Where Does Compound Tirzepatide Stand 3/19/25 Dave Knapp Mar 19, 20253 min read Compound Tirzepatide: Im Just Weary of it All Dave Knapp Mar 15, 20252 min read Judge Denies OFAs Injunction: Compounded Tirzepatide Faces Imminent FDA Enforcement Amid New Direct-to-Consumer Options Dave Knapp Mar 6, 20252 min read OFA Fires Back at FDA in Tirzepatide Case, Redactions Raise Questions as Decision Looms Dave Knapp Feb 25, 20253 min read 19:43 08:26 31:45 14:53 12:03 21:05 23:32 11:42 12:42 01:06:25 09:51 24:34 26:44 26:13 07:24 26:23 17:35 03:28
Studies in lab settings suggest that GLP-1 receptor agonists can protect brain health by lowering inflammation, boosting mitochondrial function, and improving neuronal communication
its a different mechanism
Nature 196 , 278279 (1962)
Studies show that those who combine Semaglutide with healthy eating and movement experience better and longer-lasting weight loss
GLP-1 medications are self-administered injections taken once weekly
